Systemic AL Amyloidosis in Patients Younger Than 40 Years of Age: Clinical Presentation and OutcomesKarina Verma, Vaishali Sanchorawala, Andrew Staron et al.|Clinical Lymphoma Myeloma & Leukemia|2024Cited by 1
Clinical Characteristics and Treatment Outcomes of Patients with AL Amyloidosis with Acquired Factor X DeficiencyOkan Çetin, Raphaël Szalat, Patric Teodorescu et al.|Blood|2024Cited by 1
Bleeding Patterns and Clinical Outcomes in Patients With Systemic <scp>AL</scp> Amyloidosis‐Related Acquired Factor X DeficiencyOkan Çetin, Raphaël Szalat, J. Mark Sloan et al.|American Journal of Hematology|2025Cited by 1
Rare dual-clone phenomenon: concurrent λ AL amyloidosis and κ-restricted Bcell lymphoproliferative disordersOkan Çetin, Vaishali Sanchorawala, Tracy Joshi et al.|Haematologica|2026Cited by 0